(Q41985252)

14 October 2017

EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent model (English)

1 reference

invasive pulmonary aspergillosis

14 October 2017

0 references

1 reference

Ray Hachem

1

1 reference

14 October 2017

Paul Bahna

2

1 reference

14 October 2017

Hend Hanna

3

1 reference

14 October 2017

L Clifton Stephens

4

1 reference

14 October 2017

Issam Raad

5

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

Antimicrobial Agents and Chemotherapy

14 October 2017

1 reference

14 October 2017

50

1 reference

14 October 2017

5

1 reference

14 October 2017

1823-1827

1 reference

Human salivary mucin MUC7 12-mer-L and 12-mer-D peptides: antifungal activity in saliva, enhancement of activity with protease inhibitor cocktail or EDTA, and cytotoxicity to human cells

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Therapeutic outcome in invasive aspergillosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Aspergillus infections: problems in diagnosis and treatment.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Infections with Aspergillus species.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

Experimental lead nephropathy: treatment with calcium disodium ethylenediaminetetraacetate

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472214

The effect of ethylenediamine-tetraacetic acid on Candida albicans

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16641455

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Trends in the postmortem epidemiology of invasive fungal infections at a university hospital

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16641455

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.50.5.1823-1827.2006

1 reference

14 October 2017

1 reference

14 October 2017

PubMed publication ID

16641455

1 reference